Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-17

FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA granted a supplemental approval for TRULICITY (dulaglutide) from Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRULICITY (DULAGLUTIDE)

Snippet

SUPPL AP for TRULICITY (DULAGLUTIDE)